Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jiuyang Xu and Xiaoying Gu.
Jiuyang Xu
Connection Strength
1.143
Xiaoying Gu
  1. The Effect of Prior Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Treatment on Coronavirus Disease 2019 (COVID-19) Susceptibility and Outcome: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021 06 01; 72(11):e901-e913.
    View in: PubMed
    Score: 0.237
  2. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front Med. 2020 Oct; 14(5):601-612.
    View in: PubMed
    Score: 0.223
  3. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021 Dec; 10(1):664-676.
    View in: PubMed
    Score: 0.061
  4. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021 08 28; 398(10302):747-758.
    View in: PubMed
    Score: 0.060
  5. Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial. Clin Infect Dis. 2021 05 18; 72(10):e545-e551.
    View in: PubMed
    Score: 0.059
  6. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 01 16; 397(10270):220-232.
    View in: PubMed
    Score: 0.058
  7. Risk Factors of Viral RNAaemia and Its Association With Clinical Prognosis Among Patients With Severe COVID-19. Chest. 2021 04; 159(4):1382-1386.
    View in: PubMed
    Score: 0.058
  8. Remdesivir and COVID-19 - Authors' reply. Lancet. 2020 10 03; 396(10256):954.
    View in: PubMed
    Score: 0.057
  9. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19. Clin Microbiol Infect. 2021 Jan; 27(1):112-117.
    View in: PubMed
    Score: 0.057
  10. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020 09; 56(3).
    View in: PubMed
    Score: 0.056
  11. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 05 16; 395(10236):1569-1578.
    View in: PubMed
    Score: 0.055
  12. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 05 07; 382(19):1787-1799.
    View in: PubMed
    Score: 0.055
  13. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 03 28; 395(10229):1054-1062.
    View in: PubMed
    Score: 0.054
  14. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 02 15; 395(10223):497-506.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.